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T
he drive to breathe is a fundamental human and 
biologic behavior, regulated by a complex system 
of checks and balances in the body. When respira-
tory mechanics are deregulated by injury, infection, coma, 
or a host of other conditions, the biologic equilibrium shifts 
into a state of respiratory failure. When this occurs, me-
chanical ventilation can be a life saving therapy. While 
commonplace in developed countries, critical care is at its 
infancy in many developing countries [1], where basic 
technology is often not available. Thus, while many lives 
are saved in developed nations through the provision of 
mechanical ventilation, patients in many developing na-
tions often die from otherwise reversible causes due to lack 
of resources, education, and training.
In this viewpoint paper, we will explore arguments in sup-
port of and against the provision of one vital resource – me-
chanical ventilators – in resource–poor settings. Further-
more, we will address both the benefits and challenges in 
implementing a program of increased provision of mechan-
ical ventilators. Lastly, we will provide some solutions to 
address potential barriers to this initiative.
BURDEN OF RESPIRATORY FAILURE  
IN DEVELOPING COUNTRIES:  
A CHALLENGE
Much of our data about the burden of respiratory failure 
worldwide comes primarily from developed nations. Un-
fortunately, because the disparity in quality of care within 
developing countries is wide [2], no reliable comparative 
epidemiological data of critical illness syndromes, such as 
acute lung injury and sepsis, are available. While respira-
tory failure may be fairly easy to diagnose clinically (such 
as hypoxia or increased work of breathing), it is a conse-
quence of a primary disease process (ie, pneumonia) – thus, 
as a secondary process, collection of epidemiologic data are 
challenging in resource–poor settings. This results in the 
comparative epidemiology (between resource–intensive 
and resource–poor settings) of critical illness and respira-
tory failure being heterogeneous [3,4]. Furthermore, mor-
tality after critical illness is related to both clinical decisions 
to limit intensive care and the consequences of the disease; 
therefore, countries with the resources to provide intensive 
care for patients with comorbid illnesses will have a per-
ceived higher burden of critical illness associated with these 
disorders compared to countries which do not initiate treat-
ment in the first place.
With a potentially high burden and mortality of respira-
tory failure in developing nations, the provision of mechan-
ical ventilators may help save lives if implemented in a 
thoughtful fashion. Thus, good outcomes in this patient 
population may contribute to healthier patients with better 
future productivity and economic potential. Despite this, 
several barriers to implementing a greater number of ven-
tilators exist, including perceived high cost, the need for 
education, and a lack of research in ventilator protocols for 
resource–poor settings.
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BENEFITS OF THE PROVISION OF 
VENTILATORS IN DEVELOPING 
COUNTRIES
As previously mentioned, the epidemiologic data regarding 
the burden of respiratory failure in developing countries is 
poor and may potentially be underrepresented due to large 
proportion of uncaptured data in patients in whom inten-
sive care was never initiated in the first place due to per-
ceived futility of treatment. Although classically thought to 
only benefit a small segment of patients, mechanical ven-
tilation actually can help a wide variety of patients includ-
ing patients with injury, non–communicable diseases 
(NCDs), and communicable diseases such as the human 
immunodeficiency virus (HIV) and malaria. For example, 
while it has been recognized that NCDs are beginning to 
account for a larger burden of disease in developing coun-
tries [5], decompensated NCDs (ie, heart failure exacerba-
tions) commonly require critical care and mechanical ven-
tilation. In the same vein, a patient with HIV infection may 
also decompensate from the acquisition of opportunistic 
infections and require mechanical ventilation.
Youth are often are disproportionately affected by critical 
illness and respiratory failure in the developing world; 
thus, a large amount of patients who have many years of 
contribution to society needlessly die due primarily to a 
lack of resources and education [6]. Furthermore, the lim-
ited data comparing critical care in Europe versus develop-
ing nations confirms that patients in developing countries 
tended to be younger and had an improved prior health 
status [7,8]; thus, the potential for recovery and productiv-
ity exists. An example of this situation is care for young 
patients with traumatic brain injury (TBI). In developed 
nations, TBI outcomes have significantly improved through 
careful adherence to the Brain Trauma Foundation guide-
lines, which emphasize appropriate respiratory care and 
oxygenation of the brain–injured patient [9]. In develop-
ing countries, unfortunately, many of these young patients 
are not given a chance for survival because of the lack of 
basic ventilators for respiratory support.
While mechanical ventilation can be viewed as a prolonged 
task in some patients, the majority of patients would only 
require a short course of mechanical ventilation.This is be-
cause the four most common admission criteria requiring 
ventilation in intensive care units in developing countries 
are postsurgical treatment, infectious diseases, trauma, and 
peripartum maternal or neonatal complications [10] – the 
majority of these processes are reversible over a short pe-
riod of time. Therefore, the provision of a short duration 
of mechanical ventilation has the potential to help patients 
with a variety of reversible pathologies.
ARGUMENTS AGAINST THE PROVISION 
OF VENTILATORS IN DEVELOPING 
COUNTRIES
A primary argument against the provision of ventilators in 
developing nations is centered on the increased cost of the 
intervention. While tackling prevention, communicable 
diseases, and NCDs, the strain that providing ventilators 
puts on funding agencies can be substantial. Furthermore, 
at a very high cost per ventilator even in developed coun-
tries (average anywhere from US$ 20 000 up to US$ 
100 000), ventilators by no means are a cheap intervention. 
To address these issues, basic ventilators for developing 
countries are being developed at much lower costs. While 
the capabilities of these machines are not nearly as robust 
as more expensive machines used in developed countries, 
the vast majority of patients even in developed countries 
are ventilated for a short duration and require the “minimal 
settings” that most ventilators can provide. In addition, the 
majority evidence–based maneuvers do not require com-
plex ventilation strategies (ie, lung–protective ventilation) 
[11], and can be provided with a basic ventilator. Lastly, as 
mentioned above, funding priorities can continue to be 
met, as ventilators will improve care for patients with dis-
eases under well–funded projects (ie, decompensated HIV, 
malaria, NCDs). Even if funding for basic ventilators is pro-
vided, it will be a disproportionately small amount of fund-
ing as compared to other disease states such as HIV [12].
While we have explored the cost to society and funding 
agencies as a barrier to implementing mechanical ventilation 
in resource–poor settings, a likely important reason for ceas-
ing (or, not even starting) intensive care in developing coun-
tries is the family’s inability to keep up with the cost of caring 
for the patient – in the extreme case, sometimes driving fam-
ilies into poverty. On the other hand, if cost to the family was 
not an issue (as is the case in many developed countries), the 
challenge may shift to clinical ethics; because of religious or 
cultural beliefs coupled with a misunderstanding of treat-
ment effectiveness (a situation that is often faced in devel-
oped countries as well), patients receive mechanical ventila-
tion long after it will be of any benefit. Therefore, an ethical 
framework would be necessary to advise both doctors and 
patients of possible decisions on the withdrawal of care or 
transition to “comfort” care. Furthermore, if demand out-
The provision of mechanical ventilators in de-
veloping nations may help save many lives, 
but it must be implemented in a careful and 
thoughtful fashion.
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strips the supply of ventilators, decision rules will need to 
be put into place to ethically select which patients with ben-
efit the most from the therapy.
Aside from cost, another compelling argument against the 
provision of ventilators in resource–poor settings is the in-
adequacy of current systems to appropriately care for pa-
tients on ventilators and the ventilators themselves [13]. 
The initial of care for the patient with respiratory failure 
(ie, from trauma) is often in the field, and appropriate 
emergency medical services (EMS) training must involve 
appropriate initial care and triage of these patients.
It must be understood that mechanical ventilation is a com-
plex task more than just merely “turning on” the machine. 
The act of putting a patient on mechanical ventilation re-
quires the provision of an endotracheal tube (or tightly–fit-
ting non–invasive face mask), making adjustments to the 
machine to meet patient needs, responding to ventilator 
crises, adequate sedation of the patient, and appropriate 
patient weaning and eventual liberation of the patient from 
mechanical ventilation. Second, ventilators can be vulner-
able machines and require appropriate maintenance. Third, 
ventilators require both electricity and compressed oxygen, 
both potentially scarce resources in developing countries; 
in order to fulfill the ethic principle of equity, basic oxygen 
and electricity must be available throughout a region before 
considering the institution of mechanical ventilation. Thus, 
it is apparent that beyond simply providing ventilators to 
resource–poor settings, appropriate systems must be put 
into place to address issues of both care of the ventilated 
patient and care of the ventilator itself; the opportunity cost 
of this may involve shifting resources from other public 
health priorities, thus system changes need to be imple-
mented in a thoughtful, evidence–based manner.
OVERCOMING BARRIERS TO THE 
PROVISION OF MECHANICAL 
VENTILATION
Reaching to goal of delivering high quality respiratory care 
is lofty, but very possible with a systematic approach to 
funding, education, and research. First and foremost, edu-
cational initiatives would be needed to address several is-
sues; not only would physicians and nurses need training 
on appropriate care of the ventilated patient, but staff 
would also need to be trained on the care and maintenance 
of these machines. Second, systems would need to be in 
place to create protocols for complex processes to provide 
consistent evidence–based care to patients – checklists have 
been proven very successful in this regard. Third, several 
protocols from developed countries will likely need to be 
modified to best meet the needs and resources of develop-
ing countries [14]. Fourth, government systems would 
need to be in place to assure consistent power (ie, electric-
ity) and oxygen for the machines. Fifth, a triage system 
would likely be needed to “regionalize” care for sick and 
complex patients who require more advanced therapies be-
yond basic ventilator management. Sixth, from a donor and 
funding perspective, greater education needs to be provid-
ed to donors that critical care and mechanical ventilation 
can be cost–effective, and that most evidence–based criti-
cal care interventions tend to be inexpensive [1]. 
Furthermore, the economic implications and 
advantages of decreasing mortality in young 
populations would need to be stressed. Lastly, 
research should be performed in resource–poor 
settings to focus on needs assessment, educa-
tion, implementation, and cost–effectiveness. 
While the necessary steps above seem complex, 
we have already proven that the global health 
community can tackle complex obstacles – the 
successful implementation of HIV care (one of 
the most complex diseases known to modern 
society) in some of the world’s most destitute re-
gions is proof of this.
CONCLUSION
The first formal use of ventilators in modern 
medicine is reported to have started by Dr Bjørn 
Several barriers need to be overcome in or-
der to implement mechanical ventilation ef-
fectively and successfully in developing 
countries.
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Ibsen in Copenhagen in 1953, whose use of mechanical 
ventilation helped to save scores of lives of patients with 
polio who were dying of respiratory failure, reducing mor-
tality from 87% to 25% [15]. Over the subsequent decades, 
the use of mechanical ventilation in developed countries 
has been refined, and now is one of the defining interven-
tions of critical care medicine in the developed world. 
Through extensive experience, creation of effective sys-
tems, protocol development, and research, mechanical 
ventilation has become a life–saving intervention. Similar 
to Copenhagen in 1953, in present–day resource–poor set-
tings, the practice of intensive care is likewise in an early 
stage of development, and the provision of ventilators may 
have the potential to have a positive impact on reducing 
mortality from a myriad of etiologies. As with any new in-
tervention, providing ventilators to developing nations 
comes with not only benefits, but also a host of new chal-
lenges to overcome. The key to moving forward is to help 
funding agencies understand the benefits, while putting 
together a detailed plan (as outlined above) to address the 
limitations. With this understanding, the provision of me-
chanical ventilators to developing countries has the unique 
potential to help make a dramatic improvement in the care 
of the world’s most vulnerable patients.
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